Skip to main content
. Author manuscript; available in PMC: 2014 Feb 5.
Published in final edited form as: Mol Pharm. 2012 Nov 16;9(12):3586–3594. doi: 10.1021/mp3005269

Figure 2.

Figure 2

Serial coronal PET images of 4T1 tumor-bearing mice at 0.5, 2, 4, and 8 h post-injection of 61Cu-NOTA-K3-VEGF121, or a 100 μg dose of K3-VEGF121 before 61Cu-NOTA-K3-VEGF121 administration (i.e. blocking). Images are representative of 4 mice per group and the 4T1 tumors are indicated by arrowheads.